Skip to content
Back to stories

Entrepreneurship & Growth

3 Exciting Entrepreneurs: Medtech and Biotech Founders Improving Care

20 November 2026 · 3 min read

The Legacy Bench graphic reading 3 Exciting Entrepreneurs: Medtech and biotech founders, featuring Dr Max Munford, Kiren Baines-Mortimore and Kara Egan

Medical technology and biotech are some of the hardest areas to build a company in. Products take years to develop, must pass strict regulatory checks and need the trust of doctors and patients. When they succeed, though, they can change lives on a very large scale.

This week we are looking at three founders working in this space. Two are in the UK, in London and Bristol, and one is in the United States. One is building a new kind of knee replacement, one is developing treatments for Parkinson's disease, and one has made cervical cancer screening possible at home.

They are at different stages of the journey, from early research to products already with patients, which makes them a useful picture of how health innovation develops over time.

One of the three comes straight out of academic research, from a PhD at Imperial College London, and another is tackling the underlying biology of Parkinson's disease. The link between universities and companies is one of the UK's real strengths, and OSSTEC is a good example of it in action. Valaya shows how much ambition there is at the earliest stage of the journey. The third shows what is possible once a product has passed the regulators and reached patients.

Dr Max Munford, OSSTEC

Dr Max Munford founded OSSTEC in 2021, based on his PhD research at Imperial College London. The company makes 3D-printed, cementless partial knee replacement systems.

On 3 November 2026 OSSTEC announced an $8m (£6m) funding round led by Embryo Ventures. The money will fund US regulatory approval and surgeon training, ahead of the US rollout of its first product, called Ascent.

Turning a PhD into a product that surgeons can use takes years of work. OSSTEC is a good example of a university spinout moving from the lab towards real patients, and of the careful steps, like regulatory approval and training, that have to come first.

Read more about OSSTEC: Imperial College London

Kiren Baines-Mortimore, Valaya

Kiren Baines-Mortimore is a co-founder of Valaya, a Bristol biotech company. Valaya is developing precision RNA therapeutics that target the biological drivers of Parkinson's disease.

In August 2026 Baines-Mortimore was named in Innovate UK's 2026 Women in Innovation cohort of 100 women founders.

Parkinson's affects many people and their families, and new approaches to treatment are badly needed. Valaya is at an earlier stage than the other two companies here, but recognition from a national programme is an encouraging sign for the work ahead.

Read more about Valaya: UKRI

Kara Egan, Teal Health

Kara Egan is co-founder and chief executive of Teal Health, a US company. It sells the Teal Wand, an FDA-authorised device that lets patients collect their own sample for HPV cervical cancer screening at home and post it to a lab.

In September 2026 Teal Health raised a $22m Series A led by .406 Ventures, with Labcorp and Serena Ventures among the investors. That took its total funding to $45m.

For some people, finding the time to book and attend a screening appointment is a real barrier. An authorised option they can use at home could help more people get screened, which is why this kind of product matters.

Find out more: getteal.com

Seen side by side, these three businesses cover the whole arc of health innovation: research that may lead to new medicines, a device preparing for launch in a new market, and a product already helping patients at home.

For founders in any field, the lesson is about patience and proof. In health, you cannot skip the evidence, and the companies that succeed are the ones that build trust step by step.

What founders can take from this

  • Respect the long road. OSSTEC's new funding goes into regulatory approval and surgeon training before its US launch.

  • Start from deep science. OSSTEC grew from PhD research, and Valaya is working on the biology behind Parkinson's.

  • Remove the barrier. Teal Health makes an important test easier to do, which can change behaviour.

Want more real stories from people building businesses? Watch The Legacy Bench on YouTube: youtube.com/@thelegacybench.

Sources

Keep reading